Center Trials & Treatment Europe

Center Trials & Treatment Europe is a clinical research organization and trial sponsor based in Poland, specializing in the development and execution of clinical studies for oncology and other therapeutic areas. The company is notably involved in advancing innovative drug delivery methods, such as the intranasal administration of temozolomide for brain tumors and the use of afatinib in combination with talcum for lung cancer. Center Trials & Treatment Europe collaborates with international pharmaceutical companies and research institutions to manage Phase 1 and Phase 2 clinical trials. Their expertise spans across regulatory submissions, site management, and patient recruitment within the European clinical trial landscape.